[go: up one dir, main page]

PE20060630A1 - Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie - Google Patents

Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie

Info

Publication number
PE20060630A1
PE20060630A1 PE2005000956A PE2005000956A PE20060630A1 PE 20060630 A1 PE20060630 A1 PE 20060630A1 PE 2005000956 A PE2005000956 A PE 2005000956A PE 2005000956 A PE2005000956 A PE 2005000956A PE 20060630 A1 PE20060630 A1 PE 20060630A1
Authority
PE
Peru
Prior art keywords
acid
amides
alkyl
inhibitors
carboxyl
Prior art date
Application number
PE2005000956A
Other languages
English (en)
Inventor
David Marc Fink
Yulin Chiang
Nicola Dawn Collar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of PE20060630A1 publication Critical patent/PE20060630A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO DE AMIDA SUSTITUIDA DE ACIDO TIENOPIRROLCARBOXILICO O DE ACIDO PIRROLOTIAZOLCARBOXILICO DE FORMULAS I Y II, DONDE X ES S O S(O)m; R1 ES H O ALQUILO C1-C6; R2 ES NR5R6; R3 ES ARILO O HETEROCICLO; R4 ES H, ALQUILO C1-C6, ALCOXI C1-C6, ENTRE OTROS; R5 ES H O ALQUILO C1-C6; R6 ES H O ALQUILO C1-C6; L ES N O CR7; R7 ES H O ALQUILO C1-C6; M ES S, O, NR8; R8 ES H, ALQUILO C1-C6, ENTRE OTROS; n ES 1 O 2. SON COMPUESTOS PREFERIDOS: AMIDA DEL ACIDO 6-FENILSULFANIL-4H-TIENO[3,2-b]PIRROL-5-CARBOXILICO, AMIDA DEL ACIDO 6-(3-FLUOROFENIL-SULFANIL)-4H-TIENO[3,2-b]PIRROL-5-CARBOXILICO, AMIDA DEL ACIDO 6-(4-CLOROFENIL-SULFANIL)-4H-TIENO[3,2-b]PIRROL-5-CARBOXILICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA CASEINA CINASA I EPSILON Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, INCLUYENDO TRASTORNOS DEL ANIMO Y TRASTORNOS DEL SUENO
PE2005000956A 2004-08-19 2005-08-17 Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie PE20060630A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
PE20060630A1 true PE20060630A1 (es) 2006-08-03

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000956A PE20060630A1 (es) 2004-08-19 2005-08-17 Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie

Country Status (30)

Country Link
US (2) US7393867B2 (es)
EP (1) EP1784409B1 (es)
JP (1) JP4869232B2 (es)
KR (1) KR20070045263A (es)
CN (1) CN100562521C (es)
AR (1) AR051008A1 (es)
AT (1) ATE471326T1 (es)
AU (1) AU2005272584B2 (es)
BR (1) BRPI0514419A (es)
CA (1) CA2577879C (es)
CY (1) CY1110775T1 (es)
DE (1) DE602005021889D1 (es)
DK (1) DK1784409T3 (es)
ES (1) ES2347166T3 (es)
GT (1) GT200500215A (es)
HR (1) HRP20100475T1 (es)
IL (1) IL181158A0 (es)
JO (1) JO2629B1 (es)
MY (1) MY139831A (es)
PA (1) PA8642801A1 (es)
PE (1) PE20060630A1 (es)
PL (1) PL1784409T3 (es)
PT (1) PT1784409E (es)
RS (1) RS51413B (es)
RU (1) RU2403257C2 (es)
SI (1) SI1784409T1 (es)
SV (1) SV2006002190A (es)
TW (1) TWI372149B (es)
UY (1) UY29077A1 (es)
WO (1) WO2006021000A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551952A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole daao inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
WO2007081542A2 (en) 2006-01-06 2007-07-19 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
RU2470011C2 (ru) 2007-05-31 2012-12-20 Сепракор Инк. Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
US9018238B2 (en) 2009-02-12 2015-04-28 Pharmadesign, Inc. Inhibitor of casein kinase 1δ and casein kinase 1ε
SG176574A1 (en) * 2009-05-28 2012-01-30 Vertex Pharma Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
EP2493876B1 (en) * 2009-10-28 2014-02-12 Pfizer Inc Imidazole derivatives as casein kinase inhibitors
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
WO2012020726A1 (ja) 2010-08-09 2012-02-16 株式会社ファルマデザイン カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
AU767800B2 (en) * 1999-06-08 2003-11-27 Aventisub Ii Inc. Screening methods for altering circadian rhythm proteins
CA2549183A1 (en) * 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Also Published As

Publication number Publication date
CA2577879A1 (en) 2006-02-23
RU2403257C2 (ru) 2010-11-10
US20070299112A1 (en) 2007-12-27
CA2577879C (en) 2011-07-12
PA8642801A1 (es) 2006-05-16
ES2347166T3 (es) 2010-10-26
WO2006021000A2 (en) 2006-02-23
BRPI0514419A (pt) 2008-06-10
US7393867B2 (en) 2008-07-01
PL1784409T3 (pl) 2010-10-29
AR051008A1 (es) 2006-12-13
HK1105198A1 (en) 2008-02-06
US7652046B2 (en) 2010-01-26
RS51413B (sr) 2011-02-28
AU2005272584B2 (en) 2010-11-11
SI1784409T1 (sl) 2010-10-29
RU2007109812A (ru) 2008-09-27
HRP20100475T1 (hr) 2010-10-31
AU2005272584A1 (en) 2006-02-23
WO2006021000A3 (en) 2006-06-15
EP1784409B1 (en) 2010-06-16
PT1784409E (pt) 2010-09-06
DE602005021889D1 (en) 2010-07-29
CN100562521C (zh) 2009-11-25
KR20070045263A (ko) 2007-05-02
CY1110775T1 (el) 2015-06-10
MY139831A (en) 2009-10-30
DK1784409T3 (da) 2010-09-27
IL181158A0 (en) 2007-07-04
JO2629B1 (en) 2012-06-24
ATE471326T1 (de) 2010-07-15
GT200500215A (es) 2006-03-27
CN101001861A (zh) 2007-07-18
SV2006002190A (es) 2006-05-24
JP2008510712A (ja) 2008-04-10
TWI372149B (en) 2012-09-11
UY29077A1 (es) 2006-03-31
US20080227822A1 (en) 2008-09-18
TW200621788A (en) 2006-07-01
JP4869232B2 (ja) 2012-02-08
EP1784409A2 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
PE20060630A1 (es) Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie
PE20090556A1 (es) DERIVADOS DE 6-CICLOAMINO-3-(PIRIDIN-4-IL) IMIDAZO [1,2-b]-PIRIDAZINA COMO INHIBIDORES DE CASEINA QUINASAS Y SU PREPARACION
PE20121352A1 (es) Derivados de heteroarilo que contienen n como inhibidores de cinasa jak3
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
AR069510A1 (es) Arilo y heteroarilo imidazo[1,5-a]pirazinas fusionadas como inhibidores de la fosfodiesterasa 10
CY1108908T1 (el) Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4
YU59602A (sh) Aril fuzionisana azapoliciklična jedinjenja
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
DE602004020685D1 (de) Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3-cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon
EA200970637A1 (ru) 2-замещенные-6-гетероциклилпроизводные пиримидона в качестве ингибиторов тау-протеинкиназы
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
CY1124346T1 (el) ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ
PE20050141A1 (es) DERIVADOS DE 2-ALQUINIL-Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIDINA COMO ANTAGONISTAS DEL RECEPTOR A2a ADENOSINA
NO20080393L (no) Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
CA3242851A1 (en) PYRIDAZINYL AMINO DERIVATIVES USED AS ALK5 INHIBITORS
ES2676198T3 (es) Derivados amino-quinoxalina para el tratamiento de enfermedades neurodegenerativas
GB0507601D0 (en) Compounds
DE602005008633D1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin-derivative zur behandlung kognitiver störungen
PE20040605A1 (es) Nuevas diamidas del acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de colagenesas
EA202190322A1 (ru) ИМИДАЗО[1,2-b]ПИРИДАЗИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ TRK
AR002755A1 (es) Compuestos antimicrobianos ciclohexenilo y ciclohexilo 2-disubstituidos, procedimiento para su preparacion y composiciones farmaceuticas que loscontienen.
PE20060498A1 (es) Amidas del acido 5 y 6-aminoalquil indol-2-carboxilico 3-sustituidas y analogos relacionados como inhibidores de la caseina cinasa i(epsilon)
MXPA06000892A (es) Compuestos azapoliciclicos arilo fusionados.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed